Systemic sclerosis & Raynaud's

Evaluation of left cardiac chamber function with cardiac magnetic resonance and association with outcome in patients with systemic sclerosis

Rheumatology (Oxford)Published Cohort study

Authors' conclusion

In patients with SSc, LARS was independently associated with the presence of NYHA class II-IV heart failure symptoms. Although both LARS and LV GLS were associated with all-cause mortality, only LARS provided incremental value over all evaluated variables known to be prognostically important in patients with SSc.

Study context

Population
Patients with SSc who underwent cardiovascular magnetic resonance (CMR) imaging at two tertiary referral centres (median age 54 [IQR 46–64] years, 42% male)
Participants
100 patients
Outcome
Association of LARS and LV GLS with NYHA class II-IV heart failure symptoms and all-cause mortality
Methodological detailstwo tertiary referral centres, feature-tracking CMR
  • Two tertiary referral centres
  • Feature-tracking CMR

Main finding

As reported in the abstract

Median left ventricular (LV) global longitudinal strain (GLS)
−21.8%
Median left atrial reservoir strain (LARS)
36%
LARS independently associated with New York Heart Association (NYHA) class II-IV HF symptoms (multivariable logistic regression), OR per %
0.964 (95% CI 0.929, 0.998, P = 0.049)
All-cause mortality over median follow-up of 37 (21-62) months
24 (24%)
LARS and all-cause mortality (univariable Cox), HR per 1%
0.94 (95% CI 0.91, 0.97, P < 0.0001)
LV GLS and all-cause mortality (univariable Cox), HR per %
1.10 (95% CI 1.03, 1.17, P = 0.005)

Observational data: associations, not effects.

Original publication

Evaluation of left cardiac chamber function with cardiac magnetic resonance and association with outcome in patients with systemic sclerosis. Rheumatology (Oxford). Published 28 April 2022. doi:10.1093/rheumatology/keac256

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.